Pertussis pathophysiology

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Pertussis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Pertussis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pertussis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pertussis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pertussis pathophysiology

CDC onPertussis pathophysiology

Pertussis pathophysiology in the news

Blogs on Pertussis pathophysiology

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pertussis pathophysiology

Overview

Pertussis is primarily a toxin-mediated disease. Bordetella pertussis attaches to the cilia of the respiratory epithelial cells, proliferates and produces virulence factors that paralyze the cilia, and causes inflammation of the respiratory tract, which interferes with the clearing of pulmonary secretions.[1]

Pathophysiology

Pathogenesis

  • Bordetella pertussis has tropism for pulmonary tissue and rarely disseminates to other organs.
  • The steps involved in the pathogenesis of pertussis include the following:
  • Inoculation
  • Attachment to the respiratory epithelium
  • Proliferation
  • Production of virulence factors (toxins)
  • Evasion of host immune cells
  • Tissue destruction

Virulence Factors

Bordetella pertussis produces multiple antigenic and biologically active virulence factors responsible for the clinical manifestations of pertussis. These virulence factors include:[1]

  • Pertussis toxin (PT)
  • PT undergoes ADP-ribosylation of G proteins to disrupt signal transduction in host cells.
  • Filamentous hemagglutinin (FHA)
  • Suface protein responsible for the interaction and adhesion between host cells and Bordetella pertussis.
  • FHA is a component of the acellular DTaP vaccine.
  • Agglutinogens
  • Adenylate cyclase toxin (ACT)
  • ACT delivers an adenylate cyclase domain into the host cell and increases the intracellular cAMP concentration.
  • Following cAMP delivery, phagocyte activity is inhibited, and phagocytes undergo apoptosis.
  • Pertactin (PRN)
  • PRN defends Bordetella pertussis against the host neutrophil (immunomodulation).
  • PRN is a component of the acellular DTaP vaccine.
  • Tracheal cytotoxin
  • TCT is responsible for the death of host respiratory cells using intracellular IL-1 and nitric oxide.
  • Lipooligoosaccharide (LOS)
  • Dermonecrotic toxin (DNT)
  • DNT de-aminates signaling proteins (similar mechanism to Pasteurella multicida leukotoxin).
  • Unique outer membrane component that is thought to play a role in clinical manifestations of pertussis.
  • Unknown virulence mechanism.
  • Fimbriae (FIM)
  • Surface appendages to adhere to host cells and avoid host immune cells (immunomodulation).
  • FIM is a component of the acellular DTaP vaccine.

References

Template:WH Template:WS